Publicaciones en colaboración con investigadores/as de University of Southampton (12)

2023

  1. Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial) A Multicenter, Randomized, Controlled Clinical Trial

    American Journal of Respiratory and Critical Care Medicine, Vol. 208, Núm. 3, pp. 256-269

2022

  1. Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia

    Nature Reviews Endocrinology, Vol. 18, Núm. 6, pp. 366-384

  2. Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism

    Nutrients, Vol. 14, Núm. 9

2019

  1. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort

    European Journal of Preventive Cardiology, Vol. 26, Núm. 7, pp. 764-775

2006

  1. The association between common vitamin D receptor gene variations and osteoporosis: A participant-level meta-analysis

    Annals of Internal Medicine, Vol. 145, Núm. 4, pp. 255-264

  2. Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study

    Osteoporosis International, Vol. 17, Núm. 9, pp. 1369-1381

2003

  1. Determinants of incident vertebral fracture in men and women: Results from the European Prospective Osteoporosis Study (EPOS)

    Osteoporosis International, Vol. 14, Núm. 1, pp. 19-26

2002

  1. Incidence of limb fracture across Europe: Results from the European prospective osteoporosis study (EPOS)

    Osteoporosis International, Vol. 13, Núm. 7, pp. 565-571

2001

  1. Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: Results from the European prospective osteoporosis study

    Osteoporosis International, Vol. 12, Núm. 2, pp. 85-90

2000

  1. Paroxetine was effective for reducing symptoms in social phobia: Commentary

    Evidence-Based Medicine

1999

  1. Paroxetine in social phobia/social anxiety disorder: Randomised, double- blind, placebo-controlled study

    British Journal of Psychiatry, Vol. 175, Núm. AUG., pp. 120-126

  2. Social anxiety disorder - Our current understanding

    International Journal of Psychiatry in Clinical Practice, Vol. 3, Núm. SUPPL. 3